KURA ONCOLOGY INC (KURA) Stock Analyst Earnings Estimates
NASDAQ:KURA - Nasdaq - US50127T1097 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 233.30% | N/A 479.89% | N/A 68.54% | N/A 72.75% | N/A 62.79% | N/A 69.72% | N/A -26.59% | N/A 10.66% | |||||||||||
| EBITDA YoY % growth | -1.93M | -23.62M -1,123.83% | -28.34M -19.98% | -36.05M -27.21% | -62.87M -74.40% | -67.48M -7.33% | -91.71M -35.91% | -130.7M -42.51% | -139.11M -6.43% | -164.955M -18.58% | N/A -44.72% | N/A -8.59% | N/A -8.09% | N/A -38.72% | N/A 51.12% | N/A 68.33% | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.93M | -23.64M -1,124.87% | -28.37M -20.01% | -36.08M -27.18% | -62.88M -74.28% | -67.48M -7.32% | -91.9M -36.19% | -131.26M -42.83% | -139.87M -6.56% | -165.804M -18.54% | N/A -37.68% | N/A 9.11% | N/A 20.00% | N/A 19.94% | N/A 68.67% | N/A 590.68% | N/A 171.11% | N/A -26.35% | N/A 29.21% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -1.47 44.14% | -1.54 -4.76% | -1.73 -12.34% | -1.50 13.29% | -1.69 -12.67% | -1.96 -15.98% | -2.03 -3.57% | -2.08 -2.46% | N/A -1.50% | N/A -10.60% | N/A 2.02% | N/A 41.67% | N/A 87.14% | N/A 1,508.20% | N/A 175.44% | N/A -35.25% | N/A 36.75% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 28.27% | -0.71 -20.28% | -0.74 -24.97% | -0.77 -22.12% | -0.58 -48.11% |
| Revenue Q2Q % growth | 30.388M | 14.28M -53.01% | |||
| EBITDA Q2Q % growth | -63.281M -37.83% | -66.137M -21.98% | -67.463M -20.54% | -68.809M -16.15% | -43.646M 31.03% |
| EBIT Q2Q % growth | -59.256M -26.72% | -64.507M -18.47% | -40.537M 28.13% | -69M -15.22% | -37.031M 37.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.63 -26.00% | -0.64 | 0.01 | 1.27% |
| Q2 2024 Q2Q % growth | -0.59 -11.32% | -0.64 | 0.05 | 8.05% |
| Q1 2024 Q2Q % growth | -0.59 -18.00% | -0.56 | -0.03 | -5.24% |
| Q4 2023 Q2Q % growth | -0.55 -12.24% | -0.56 | 0.01 | 1.83% |
| Q3 2023 Q2Q % growth | -0.50 5.66% | -0.56 | 0.06 | 10.79% |
| Q2 2023 Q2Q % growth | -0.53 -1.92% | -0.56 | 0.03 | 5.51% |
| Q1 2023 Q2Q % growth | -0.50 -2.04% | -0.55 | 0.05 | 9.87% |
| Q4 2022 Q2Q % growth | -0.49 | -0.58 | 0.09 | 16.02% |
| Q3 2022 Q2Q % growth | -0.53 -6.00% | -0.57 | 0.04 | 7.54% |
| Q2 2022 Q2Q % growth | -0.52 -1.96% | -0.53 | 0.01 | 1.12% |
| Q1 2022 Q2Q % growth | -0.49 -6.52% | -0.53 | 0.04 | 7.03% |
| Q4 2021 Q2Q % growth | -0.49 -8.89% | -0.54 | 0.05 | 9.36% |
| Q3 2021 Q2Q % growth | -0.50 -19.05% | -0.55 | 0.05 | 8.89% |
| Q2 2021 Q2Q % growth | -0.51 -27.50% | -0.50 | -0.01 | -2.40% |
| Q1 2021 Q2Q % growth | -0.46 -9.52% | -0.43 | -0.03 | -7.80% |
| Q4 2020 Q2Q % growth | -0.45 -15.38% | -0.46 | 0.01 | 2.59% |
| Q3 2020 Q2Q % growth | -0.42 -16.67% | -0.40 | -0.02 | -3.88% |
| Q2 2020 Q2Q % growth | -0.40 -5.26% | -0.43 | 0.03 | 7.32% |
| Q1 2020 Q2Q % growth | -0.42 -13.51% | -0.43 | 0.01 | 1.96% |
| Q4 2019 Q2Q % growth | -0.39 | -0.42 | 0.03 | 7.70% |
| Q3 2019 Q2Q % growth | -0.36 | -0.40 | 0.04 | 9.71% |
| Q2 2019 Q2Q % growth | -0.38 | -0.42 | 0.04 | 9.55% |
| Q1 2019 Q2Q % growth | -0.37 | -0.45 | 0.08 | 18.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2020 Q2Q % growth | 51K | -51K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 42.93% | 0% | 15.04% |
| Revenue | 0% | N/A | 0% | N/A |